Jeff Yass’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.2M Sell
1,103,600
-198,000
-15% -$1.21M ﹤0.01% 3074
2026
Q1
$9.96M Buy
1,301,600
+175,000
+16% +$1.34M ﹤0.01% 3127
2025
Q4
$11M Sell
1,126,600
-670,400
-37% -$5.7M ﹤0.01% 2932
2025
Q3
$7.53M Buy
1,797,000
+1,567,700
+684% +$10M ﹤0.01% 3428
2025
Q2
$2.13M Buy
229,300
+194,600
+561% +$1.7M ﹤0.01% 5657
2025
Q1
$338K Buy
34,700
+4,300
+14% +$53.2K ﹤0.01% 9791
2024
Q4
$368K Buy
+30,400
New +$369K ﹤0.01% 9375
2024
Q3
Sell
-17,500
Closed -$158K 12855
2024
Q2
$158K Buy
17,500
+4,600
+36% +$32.1K ﹤0.01% 10648
2024
Q1
$105K Sell
12,900
-7,400
-36% -$60.7K ﹤0.01% 11185
2023
Q4
$171K Sell
20,300
-403,300
-95% -$4.68M ﹤0.01% 10838
2023
Q3
$7.25M Buy
423,600
+401,900
+1,852% +$7.89M ﹤0.01% 2972
2023
Q2
$504K Buy
+21,700
New +$424K ﹤0.01% 8297
2023
Q1
Sell
-42,300
Closed -$1.15M 13332
2022
Q4
$1.15M Buy
42,300
+500
+1% +$10.4K ﹤0.01% 5865
2022
Q3
$722K Buy
41,800
+17,500
+72% +$334K ﹤0.01% 7490
2022
Q2
$425K Buy
+24,300
New +$399K ﹤0.01% 8670

Other funds holding REPL

Jeff Yass's REPL Position: Q2 2026 in Review

Jeff Yass reduced its Replimune Group (REPL) stake by 59% in Q2 2026, selling an estimated $2.27M and leaving 253,450 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #5770.

Jeff Yass first reported a position in REPL in Q4 2020 and has held it in 21 quarters since. The position peaked at $5.9M in Q4 2025. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Jeff Yass held 253,450 shares of Replimune Group worth $2.81M as of Q2 2026.
  • Jeff Yass sold 370,529 Replimune Group shares in Q2 2026, an estimated $2.27M.
  • Replimune Group made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5770 holding.
  • Jeff Yass first reported a position in Replimune Group in Q4 2020 and has held it in 21 quarters since.
  • Jeff Yass's Replimune Group position peaked at $5.9M in Q4 2025.
  • 199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.